Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 8/20 | 1.00 |
| ▸ | PRKCG | P05129 | 8/20 | 1.00 |
| ▸ | PRKCB | P05771 | 8/20 | 1.00 |
| ▸ | PRKCA | P17252 | 8/20 | 1.00 |
| ▸ | PRKCH | P24723 | 8/20 | 1.00 |
| ▸ | PRKCI | P41743 | 8/20 | 1.00 |
| ▸ | PRKCE | Q02156 | 8/20 | 1.00 |
| ▸ | PRKCQ | Q04759 | 8/20 | 1.00 |
| ▸ | PRKCZ | Q05513 | 8/20 | 1.00 |
| ▸ | PRKCD | Q05655 | 8/20 | 1.00 |
| ▸ | PRKD1 | Q15139 | 8/20 | 1.00 |
| ▸ | RAD52 | P43351 | 2/20 | 1.00 |
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | TNNI3 | P19429 | 1/20 | 1.00 |
| ▸ | APEX1 | P27695 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Corilagin SCHEMBL21026424 | 1.00 | PRKD3 (1.00) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| Corilagin SCHEMBL14075996 | 1.00 | PRKD3 (1.00) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| Corilagin SCHEMBL30208566 | 1.00 | PRKD3 (1.00) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| Corilagin SCHEMBL29994662 | 1.00 | PRKD3 (1.00) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| Corilagin SCHEMBL14089650 | 1.00 | PRKD3 (1.00) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| Corilagin SCHEMBL18415304 | 1.00 | PRKD3 (1.00) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| Corilagin SCHEMBL13242674 | 1.00 | PRKD3 (1.00) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| SCHEMBL20409294 | 0.93 | PRKD3 (0.88) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| Strictinin SCHEMBL15262426 | 0.92 | RAD52 (1.00) | PRKD3PRKCGPRKCBPRKCAPRKCH | |
| Strictinin SCHEMBL17148972 | 0.92 | RAD52 (1.00) | PRKD3PRKCGPRKCBPRKCAPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1398 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122074627-A | Preparation method of low-GI fruit and vegetable crisp chips | — | 2026-05-26 | — | — | CN | claimed |
| CN-122012665-A | Three-fruit Shang Kangyan component high-screening method based on intestinal flora metabolic model | 青岛科技大学 | 2026-05-12 | — | — | CN | claimed |
| CN-117741031-B | Construction method, detection method and application of strong Ma De Tu Alite preparation fingerprint | 新疆维吾尔药业有限责任公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260084136-A1 | SUPERABSORBENT POLYMER, METHOD OF MAKING THE SAME, AND A FOODSTUFF PACKAGING MATERIAL INCLUDING THE SAME | FORMOSA PLASTICS CORP (TW) | 2026-03-26 | — | — | US | claimed |
| EP-4715000-A1 | SUPERABSORBENT POLYMER, METHOD OF MAKING THE SAME, AND A FOODSTUFF PACKAGING MATERIAL INCLUDING THE SAME | Formosa Plastics Corporation (TW) | 2026-03-25 | — | — | EP | claimed |
| WO-2025264604-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2025-12-26 | — | — | WO | claimed |
| US-20250381110-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | PROCTER & GAMBLE (US) | 2025-12-18 | — | — | US | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| EP-4611549-A1 | COMPOSTABLE CAPSULE AND PRODUCTION THEREOF | Delica AG (CH) | 2025-09-10 | — | — | EP | claimed |
| CN-120114873-A | Preparation method and application of phyllanthus emblica juice polyphenol extract | 广东药科大学 | 2025-06-10 | — | — | CN | claimed |
| WO-2002028403-A1 | PHYLLANTHUS-DERIVED COMPOUNDS FOR THE PREVENTION AND/OR TREATMENT OF DISEASES ASSOCIATED WITH A RETROVIRUS | CMI - CENTERS FOR MEDICAL INNOVATION AG (DE) | 2002-04-11 | — | — | WO | claimed |
| CN-1319411-A | Traditional Chinese medicine compound preparation for treating chronic hepatitis B and preparation process thereof | HOSPITAL AFFILIATED TO HUBEI T (CN) | 2001-10-31 | — | — | CN | claimed |
| EP-1144456-A2 | METHOD OF ISOLATING MUCILAGINOUS POLYSACCHARIDES AND USES THEREOF | Vito-Mannan Polysaccharide L.L.C. (US) | 2001-10-17 | — | — | EP | claimed |
| WO-2000056347-A1 | AN ENRICHED FRACTION PREPARED FROM PHYLLANTHUS AMARUS FOR THE TREATMENT OF HEPATITIS AND THE PREPARATION THEREOF | SOUTHERN PETROCHEMICAL INDUSTRIES CORPORATION LIMITED (IN) | 2000-09-28 | — | — | WO | claimed |
| WO-2000041541-A2 | METHOD OF ISOLATING MUCILAGINOUS POLYSACCHARIDES AND USES THEREOF | VITO-MANNAN POLYSACCHARIDE L.L.C. (US) | 2000-07-20 | — | — | WO | claimed |
| WO-2000027413-A1 | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEPATITIS B COMPRISING CORILAGIN OR BREVIFOLIN CARBOXYLIC ACID | HEPAGUARD CO., LTD. (KR) | 2000-05-18 | — | — | WO | claimed |
| CN-1197641-A | Medicine containing tan matter caesalpinia extract | SINO JAPAN FRIENDSHIP INST OF (CN) | 1998-11-04 | — | — | CN | claimed |
| US-5266319-A | Tannin derivatives and their use for treatment of hypertension | NATIONAL SCIENCE COUNCIL (TW) | 1993-11-30 | — | — | US | claimed |
| US-5173117-A | Hydrolyzable tannin compound, controls heat of hydration | SUMITOMO CEMENT CO. LTD. (JP) | 1992-12-22 | — | — | US | claimed |
| WO-1990004968-A1 | INHIBITION OF HUMAN RETROVIRUSES | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 1990-05-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260084136-A1 | SUPERABSORBENT POLYMER, METHOD OF MAKING THE SAME, AND A FOODSTUFF PACKAGING MATERIAL INCLUDING THE SAME | TAS2R40, SI, FTO | PRKD3 3844/4885PRKCG 4489/4885PRKCB 4506/4885 |
| US-20250381110-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | SQSTM1, BECN1, CUTA | PRKD3 1064/4885PRKCG 364/4885PRKCB 271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.